HK-listed Consun Pharma jumps most in nearly 4 months on WuXi AppTec agreement

Reuters2021-07-19

** Shares of Consun Pharmaceutical Group Ltd rise 8.7% to HK$5.47, biggest intraday jump since March 23

** Stock among 30 top gainers on the Hong Kong bourse, hits highest since June 11

** Guangdong-based co says its unit has entered into a strategic cooperation agreement with WuXi AppTec (Shanghai) Co Ltd, a subsidiary of WuXi AppTec Co Ltd , for R&D of certain innovative drugs and other new drugs for use in treating kidney disease ()

** Hong Kong shares of Wuxi AppTec climbs 0.4% while Shanghai shares rise 1.8%

** The Hong Kong Hang Seng Commerce & Industry Index falls 1.6%, while the healthcare index gains 0.7%

** Both the Hang Seng China Enterprises Index and the benchmark index drop 1.8%

** As of last close, the stock of Consun had soared 64.9% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
16